[Evaluation of the efficacy of a comprehensive programme of secondary prevention of cardiovascular disease in primary care: the PREseAP Study].
作者信息
Brotons C, Ariño D, Borrás I, Buitrago F, González M L, Kloppe P, Orozco D, Pepió J M, Rodríguez P, Rodríguez A I
机构信息
Unidad de Investigación, EAP Sardenya, Equip d'Atenció Primària Sardenya, Barcelona, Spain.
出版信息
Aten Primaria. 2006 Mar 31;37(5):295-8. doi: 10.1157/13086317.
OBJECTIVES
To assess the efficacy of a comprehensive secondary prevention programme to reduce morbidity and mortality in patients who have suffered a cardiovascular (CV) event; to control CV risk factors and prophylactic treatment in order to prevent recurrence; and to improve the quality of life of patients with cardiovascular disease.
DESIGN
Randomised, pragmatic, open clinical trial in primary care.
SETTING
A total of 42 primary care centres of 8 different areas in Spain.
PARTICIPANTS
Men and women below 86 years old, diagnosed with coronary disease and/or stroke and/or peripheral vascular disease in the preceding year, and who have no serious or terminal disease.
INTERVENTION
Primary care centres will be randomised to following usual care (control group), or to following a comprehensive programme of secondary prevention (intervention group).
MAIN MEASUREMENTS
Cardiovascular fatal events, cardiovascular non-fatal events, total mortality and health-related quality of life (SF-36).
Zotero 插件